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ABSTRACT 
 
Changes in lipid profile are common in adult patients with malaria, but only a few studies have 
evaluated such lipid abnormalities in uncomplicated falciparum malaria cases from the South 
America. This is a prospective study designed to evaluate transient lipid abnormalities in adults with 
uncomplicated falciparum malaria as well as to assess if the parasite count correlates with the lipid 
levels at admission. A total of 60 adult males were included in the study, of which 30 had the slide-
confirmed infection by P. falciparum. Serial blood samples were collected at admission and on days 
3, 14 and 43. Triglycerides, total cholesterol, high-density lipoprotein (HDL-c), and low-density 
lipoprotein (LDL-c) were measured by colorimetric methods. At admission, the levels of total 
cholesterol, LDL and HDL were significantly lower in malaria cases compared to healthy controls, 
but the levels of triglycerides were significantly higher in these patients. There are significant 
changes in lipid levels in the follow up. The lipid levels were not associated with the parasite count. 
In conclusion, there are significant lipid abnormalities in the adults with low levels of P. falciparum 
infection and mild signs and symptoms of the disease, which are not associated with parasitemia at 
admission. 
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1. INTRODUCTION 
 
Malaria by P. falciparum is still a relevant public 
health issue worldwide. In the Brazilian Amazon 
basin, approximately 15,000 cases occurred in 
2015 [1]. Repeated episodes of the disease are 
common in this area, which confers to the native 
population a partial immunity, and only a few 
cases progress to severe illness with cerebral or 
renal impairment. Overall, patients have low 
parasite density and mild signs and symptoms 
[2-4]; however, laboratory abnormalities are often 
reported in the acute phase of the disease, such 
as anaemia, thrombocytopenia, hypoglycaemia, 
and of the lipid profile [5-7]. 
 
The latter is common in the acute or chronic 
phases of infectious or inflammatory diseases 
[8,9]. Low levels of total cholesterol, high-density 
lipoproteins (HDL-c) and low-density lipoproteins 
(LDL-c) accompanied by high levels of 
triglycerides and very low-density lipoproteins 
(VLDL-c) characterize the lipid changes in 
malaria. Such abnormalities are transient; occur 
in the most prevalent species of Plasmodium as 
well as in complicated and non-complicated 
cases [10-15]. 
 
Despite the high occurrence of malaria in 
Amazon basin, only a few studies reported lipid 
changes in this endemic setting. Evaluation of 
the lipid abnormalities in the course of malaria in 
areas with high transmission rates is relevant 
since a long-term change in lipid profile can 
directly influence the risk of coronary disease 
and other related diseases [13-15]. Moreover, 
genetic ancestry influences the lipid profile of 
admixed population as that from South American 
that has different contributions of European, 
African and Amerindian ethnic ancestries [16-18]. 
Thus, the present study aims to evaluate the 
temporal changes in lipid profile of adults from 
Brazilian Amazon basin with uncomplicated 
malaria by P. falciparum and to assess if the 
parasite count correlates with the lipid levels at 
admission. 
 
2. MATERIALS AND METHODS 
  
2.1 Ethical Statement 
 
The study was submitted to Plataforma Brasil 
under protocol CAAE 2 07199612.0.0000.0018, 
and approved under the number 261.593/2013. 
Informed written consent was obtained from all 
participants. 
2.2 Study Site and Participants 
 
This was a prospective study carried out in 
Anajas at the Marajo Island. The municipality has 
an area of 6,912 Km2 and 27,540 inhabitants. 
The economy is based on agriculture practices, 
timber extraction, and fishing. The municipality 
accounts for 17.4%of malaria cases in the state 
of Para and has a constant annual incidence of 
cases above 50/1,000 inhabitants. The 
municipality have seven health public facilities, 
including an ambulatory for diagnosis and 
treatment of malaria. 
 
Participants were randomly recruited among 
those who searched for attendance at Malaria 
Ambulatory of the municipality with signals and 
symptoms suggestive of malaria. Two groups of 
male adults were included in the study: (1) case: 
male adults with slide-confirmed infection by     
P. falciparum and (2) control: male adult with a 
negative diagnosis of malaria after microscopic 
examination of three blood smears.  Exclusion 
criteria included patients with mixed malaria or 
signs and symptoms of severe malaria (jaundice, 
renal or pulmonary impairment, severe anaemia, 
altered levels of consciousness), parasitemia 
above 4%, chronic and other parasitic diseases, 
overweight and underweight individuals 
assessed by the body mass index. Individuals of 
the control group who referred history of malaria 
infection within the previous twelve months also 
were excluded from the study. 
 
2.3 Treatment and Follow-up 
 
Patients with malaria were treated with 
mefloquine and artesunate according to the 
recommendation of the World Health 
Organization [19]. The clinical staff of Malaria 
Ambulatory was responsible for prescribing and 
dispensing the anti-malarial drugs. The patients 
received specific instructions about the 
administration on each day and were strongly 
recommended to complete the course of 
treatment. Data regarding the clinical signals and 
symptoms and the history of malaria, including 
the last episode of the disease, were carefully 
recorded in an appropriate questionnaire during 
the enrolment of patients in the study.  All 
patients were requested to return for follow-up on 
days 3, 14 and 43 or at any time that signs and 
symptoms suggestive of malaria occurred. A 
parasite count was performed at each visit.     
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2.4 Blood Sampling and Laboratory 
Analysis 
 
Serial blood samples were collected in both 
groups recruited for the study on days 0, 3, 14 
and 43. Samples were collected after a fasting of 
12 h. Triglycerides, total cholesterol, HDL and 
LDL were measured by colorimetric methods 
using Roche-Diagnostic Kits in a Cobas c 111-
Roche ™, following the good laboratory practices 
[20]. All blood samples were analysed in 
triplicate. The normal ranges of each lipid 
followed the recommendations of the Brazilian 
Cardiology Society [21].   
 
2.5 Microscopic Examination 
 
Parasite counts were done every 24 hours in 
Giemsa-stained thick films until clearance.  Blood 
films were examined microscopically using 100X 
(oil immersion) objectives.  Parasite density was 
expressed as the number of parasites per 
microliter of blood. This was derived from the 
number of parasites per 200 white blood cells in 
a thick film, considering a total white blood cell 
count of 8,000. The limit of detection of parasites 
was 40/µL [22].  
 
2.6 Data Analysis 
 
Data are presented as a mean, standard 
deviation and confidence interval. The Student t-
test was used to compare lipid levels between 
cases and controls on D0.  A univariate analysis 
was used to compare lipid levels amongst days 
of blood sampling in patients with malaria. The 
Pearson coefficient of correlation was used to 
estimate the correlations between parasitemia 
with triglycerides, total cholesterol, and fractions 
on D0. Data were analysed using SPSS 
software, Release21 (IBMinc, Chicago, IL, EUA).  
The accepted significance level was 5%. 
 
3. RESULTS 
 
A total of 60 male adults met the criteria for the 
inclusion in the study. The cases of malaria 
corresponded to 50% (n=30) of the participants. 
All cases reported previous episodes of the 
disease. Moreover, all cases showed low 
parasite count and mild signals and symptoms. 
The baseline characteristics of participants are in 
Table 1. 
 
The mean total cholesterol level of the cases on 
D0 was 116 mg/dl (95% CI 103–129 mg/dl), on 
D3 was 118 mg/dl (95% CI 108–127 mg/dl), on 
D14 was 144 mg/dl (95% CI 135–152 mg/dl) and 
on D43 was 157 mg/dl (95% CI 147–168 mg/dl). 
The univariate analysis showed significant 
changes in cholesterol levels amongst days of 
the study, with the lowest values on days 0 and 3 
(F=14.95, p<0.001). The healthy controls showed 
total cholesterol mean level of 174 mg/dl (95% CI 
162–186 mg/dl), which was significantly higher 
than the cases on D0 (t=6.652, p<0.0001). 
Although the mean total cholesterol level 
increased in the follow-up of the cases, they 
were still below the controls on D43 (t=2.181, 
p=0.033). On D0, there was no significant 
correlation between the parasitemia and the total 
cholesterol (r=0.2, p=0.209). 
 
The mean HDL-c level of the cases on D0 was 
16.3 mg/dl (95% CI 11.9–20.6 mg/dl), on D3 was 
17.4 mg/dl (95% CI 14–20.8 mg/dl), on D14 was 
30 mg/dl (95% CI 27.3–32.4 mg/dl) and on D43 
was 35 mg/dl (95% CI 31–37.2 mg/dl). The 
univariate analysis showed significant changes in 
HDL-c levels amongst days of the study with the 
lowest values on Days 0 and 3 (F=28.69, 
p<0.001).  The healthy controls have an HDL-c 
mean level of 46.3 mg/dl (95% IC 41–51 mg/dl), 
which was significantly high than the cases on 
Table 1. Baseline characteristics of participants 
 
Characteristic Cases (n=30) Controls (n=30) p-value 
Age, years 33(11) 34(12) 0.521 
Parasitemia at admission, geometrical mean 3178 (7.1)   
Previous episodes of disease, number of 
cases (%) 
60 0 <0.0001 
Parasite clearance, hours 48 (20)   
Fever clearance, hours 24(12)   
Erythrocytes at admission, x106/ µl 4.29(0.79) 4.7(0.82) 0.836 
Hematocrit at admission, % 36.4(6) 39 (5) 0.331 
Hemoglobin at admission, g/dl 11.9(2) 12(2) 0.9 
Platelets at admission, x103/µl 136.9(61,1) 240.1(48.2) <0.001 
* results are expressed as mean and standard deviation 
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D0 (t=8.99, p<0.0001). The values of HDL-c of 
the cases increased in the follow-up, but they 
were still below the controls on D43                   
(t=4.12, p=0.001). At admission, there was no 
significant correlation between                       
parasitemia and HDL-c levels (r=0.0734, 
p=0.699). 
 
The mean levels of LDL-c of cases on D0 was 64 
mg/dl (95% CI48–80 mg/dl), on Day 3 was 69 
mg/dl (95% CI 55–82 mg/dl), on D14 was 95 
mg/dl (95% CI 86–105mg/dl) and on D43 was 
114 mg/dl (95% CI 104–125 mg/dl).The 
univariate analysis showed a significant 
difference amongst days of the study, with the 
lowest values on days 0 and 3 (F=14.54, 
p<0.0001). The healthy controls have an LDL-c 
mean level of 112 mg/dl (95% CI 102–121 
mg/dl), which was significantly higher than the 
cases on D0 (t=5.25, p<0.0001). However, the 
LDL-cmean levels were similar to the healthy 
control on D43 (t=0.2914, p=0.7718). On D0, 
there was no significant correlation between 
parasitemia and LDL-c levels (r=0.1804; 
p=0.3402). 
 
The mean level of triglycerides of the cases on 
D0 was 158 mg/dl (95% CI 135–181 mg/dl), on 
D3 was 152 mg/dl (95% CI 131–173 mg/dl), on 
D14 was 132 mg/dl (95% CI= 112–153 mg/dl) 
and on D43 was 122 mg/dl (95% CI 102–140 
mg/dl). The univariate analysis showed a 
significant difference in triglyceride levels 
amongst days of the study (F=2.741; p=0.0464), 
with the highest values on days 0 and 3.  The 
healthy controls had a mean level of 122 mg/dl 
(95% IC= 98–146mg/dl), which was significantly 
lower than the cases on D0 (t= 1.908, p=0.0615). 
(Fig. 1 and Fig. 2) Finally, there was no 
significant correlation between the parasitemia 
and the triglycerides levels on D0 (r= -0.2619; 
p=0.1622). 
 
4. DISCUSSION 
 
The temporal variation of lipid levels was 
examined in patients with uncomplicated malaria 
by P. falciparum from the South America. At 
admission, the levels of total cholesterol, HDL-c, 
and LDL-c were lower in malaria cases than in 
healthy controls.  On the other hand, the levels of 
triglycerides were high in malaria cases 
compared to healthy controls. These data 
confirm that patients with malaria from the              
South America have significant changes in              
lipid levels in the acute phase of the disease,              
as well as such abnormalities, are similar                     
to uncomplicated falciparum malaria cases                 
from the Africa and the Asia [10-15].  
 
Changes in lipid and lipoprotein levels occur in 
most patients with active infections caused by 
parasites, but the exact mechanism is unclear 
[8,9]. In malaria, such alterations are due to the 
Plasmodium, to human-related factors, or                 
both [10,13,14,23,24]. Plasmodium does not 
have any biological pathway for sterol synthesis 
for their metabolic requirements, such as 
membrane or hemozoin formation, and the 
cholesterol is obtained from the exogenous and 
endogenous pathways of the human host 
[25,26].   
 
 
 
Fig. 1. Lipid levels in patients with uncomplicated falciparum () malaria at enrollment in the 
study (D0) and in the control group () 
*p<0.05 
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Fig. 2. Temporal variation of lipid profiles in patients with uncomplicated falciparum malaria 
 
Abnormalities in triglycerides levels are probably 
due to the increase of VLDL production resulting 
from the excessive mobilization of free fatty acids 
from adipose tissue in response to stress due to 
the disease as well as to the impairment of the 
lipoprotein lipase system mediated through the 
levels of the tumor necrosis factor. After the 
clearance of parasites from blood, the 
triglycerides levels decreased to values similar to 
the controls. Regard to the total cholesterol and 
cholesterol-rich lipoproteins, the most significant 
impact of malaria was on HDL-c. The probable 
causes are the increased rate of HDL-C removal 
by Plasmodium, activation of the 
reticuloendothelial system leading to non-specific 
uptake of HLD-c in the phagocytic cell and 
oxidation of lipoproteins due to redox imbalance 
caused by the disease and by antimalarial drugs 
[27-33].  
  
Studies evaluating transient changes in lipid 
profiles of malaria patients have shown 
inconclusive results, ranging from a few days to 
one year [10,12,15]. In the study, the levels of 
lipids changed differently after the clearance of 
parasites at 48 hours, as for instance, 
triglycerides levels decreased rapidly in malaria 
patients with values similar to healthy controls on 
Day 3, but LDL-c, HDL-c and the total cholesterol 
levels increased slowly during follow-up. In fact, 
the total cholesterol and HDL-c levels remained 
significantly lower than to the healthy controls on 
Day 43. 
 
These changes in lipid profiles in the follow-up 
can be related to both the clearance of parasites 
and the improvement of the nutritional status of 
patients in the convalescence period 
[9,10,12,31]. Moreover, there were no significant 
correlations between the parasitemia at 
admission and the lipids levels. A plausible 
explanation is the low parasite density at 
admission in the study. 
 
5. CONCLUSION 
 
The data of the current study are relevant in the 
clinical spectrum of uncomplicated falciparum 
malaria cases, since they confirm the occurrence 
of transient changes in lipid levels, with highest 
abnormalities in the high-density lipoprotein 
levels. Finally, there are no significant 
correlations between parasitemia at admission 
and lipids levels. 
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